SUMMARY Owing to the report of an association between rheumatoid arthritis (RA) and obliterative bronchiolitis we have determined the prevalence of airflow obstruction in unselected patients with RA and normal chest radiographs. Spirometry was performed on 100 patients with rheumatoid arthritis and 84 control subjects matched for age, sex, and smoking habits. Patients with rheumatoid arthritis had significantly lower values for FEV1, FVC, FEV1/FVC, and MMEFR when compared with the controls: 39 patients had abnormal spirometry, and at least 32 showed airways obstruction. The prevalence of airflow obstruction is remarkably high, and we suggest that airway disease may be the commonest form of lung involvement in rheumatoid arthritis.
Rheumatoid arthritis (RA) is associated with a number of different lung disorders. These include pleural effusions, Caplan's syndrome, pulmonary rheumatoid nodules, fibrosing alveolitis, bronchiectasis, and a increased incidence of chest infections (Walker, 1967) . Surprisingly little attention has been paid to the airways in RA. Reports of lung function tests have been few and have either concentrated on patients with interstitial lung disease (Newcomer et al., 1964; Patterson et al., 1965; Walker and Wright, 1969) or ignored evidence of obstruction, excluding such patients (Worwell et al., 1975) or attributing the abnormalities to smoking. We have reported 6 patients with obliterative bronchiolitis (Geddes et al., 1977a) and suggested an association between RA and airway disease. In order to assess the prevalence of airflow obstruction in RA we have, therefore analysed the spirograms from 100 consecutive patients with RA obtained in a prospective study.
Patients and methods any patient with significant chest x-ray abnormality was excluded. Eighty-four healthy control subjects with normal chest x-rays were also tested. These were referred for routine chest x-ray for insurance purposes or before taking up employment. They were matched with the rheumatoid patients for age, sex, and smoking habits as shown in Table 1 This allows a much wider range of normal than is usual in most lung function laboratories. Nevertheless, 24% of the patients with RA had a low FEV1/FVC and 38% had a low MMEFR. Since a number of individuals had more than 1 abnormal measurement, the abnormalities are summarised by patients in Table 4 . The most sensitive test was the MMEFR, which was lower in patients with RA than controls for all decades except 20-29 years. The mean MMEFR (% predicted) for each decade fell with age in the patients with RA but was constant in the controls. The t test for independent means was used for statistical analysis. The data were normally distributed as judged by the Kolmogorov-Smirnov D statistic. (Green, 1977) , and on this basis the results of these 6 patients may be interpreted as showing small airways obstruction without the need to postulate any fibrosis. If this interpretation is correct, the prevalence of airflow obstruction in our rheumatoid patients is 38 %.
The role of muscular weakness in causing these spirometric abnormalities must be considered. Weakness results in a reduction of vital capacity. The FEV1 is less affected, since most of the forced expiratorymanoeuvre iseffort-independent; muscular weakness therefore causes a rise in the FEV,/FVC ratio. The MMEFR is effort-independent and will not be affected by muscular weakness.
Two possible explanations for this high prevalence of airways obstruction are worth considering. An association between RA and al antitrypsin phenotypes has been reported (Cox et al., 1976) , and this could in theory predispose some patients with RA to emphysema. However, in a separate study (Geddes et al., 1977b) we have looked at the incidence of acl antitrypsin phenotypes in our patients with RA who also took part in this study, and found no significant association. A more attractive explanation is that the obstruction is due to frequent respiratory tract infections. The role of recurrent infections independent of smoking in causing airflow obstruction is controversial. The fact that we have matched our patients for smoking habits and found evidence of airflow obstruction in the nonsmokers is strong evidence that neither smoking itself nor an increased susceptibility to its effects is the sole cause of airflow obstruction. Walker (1967) has shown that patients with RA are more prone to respiratory tract infections than patients with osteoarthrosis, and bronchiectasis is also more common. We have reported 5 patients with RA in whom bronchiolitis caused progressive airway obliteration and respiratory failure (Geddes et al., 1977a) and have since seen others. Murphy et al. (1976) reported a similar patient with RA and severe airways disease, although they attributed this to inhalation of fumes; we could not obtain such a history in any of our patients. It appears, therefore, that patients with RA may have an increased susceptibility to airway infections or a reduced ability to control and eradicate these infections. Such a tendency may be evident as bronchiectasis or progressive airway obliteration, but the present study suggests that a defect is present in many patients without overt pulmonary disease. Walker (1967) noted that the diagnosis of bronchiectasis in his patients often preceded the development of RA. There has been much speculation about the initiating role of infective agents in the pathogenesis of RA. It may be that respiratory pathogens should be considered further in this light.
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